PRKDC and glioblastoma: To further demonstrate the specific synthetic lethal interaction in GBM cells, we treated M059K and U251 cells with two highly specific DNA-PKcs inhibitors, VX-98435, and NU-744136, upon the transfection with anti-miR-1193.